SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Walker Neal – ‘4’ for 4/1/24 re: Aclaris Therapeutics, Inc.

On:  Wednesday, 4/3/24, at 5:00pm ET   ·   For:  4/1/24   ·   As:  Director and Officer   ·   Accession #:  1415889-24-10060   ·   File #:  1-37581

Previous ‘4’:  ‘4’ on 3/5/24 for 3/1/24   ·   Latest ‘4’:  This Filing

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/03/24  Walker Neal                       4          Dir.,Off.   1:7K   Aclaris Therapeutics, Inc.        SEC Connect

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      8K 
                Securities by an Insider --                                      
                form4-04032024_090431.xml/5.8


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
SEC Info℠ rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider — form4-04032024_090431.xml/5.8
 

The SEC has not released XSLT Stylesheets needed to render this File’s XML Data as a Form.

This is our “Plain Text” rendering:
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0508
Document Type:  4
Period of Report:  4/1/24
Issuer:
Issuer CIK:  1557746
Issuer Name:  Aclaris Therapeutics, Inc.
Issuer Trading Symbol:  ACRS
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1604457
Owner Name:  Walker Neal
Reporting Owner Address:
Owner Street 1:  C/O ACLARIS THERAPEUTICS, INC.
Owner Street 2:  701 LEE ROAD, SUITE 103
Owner City:  WAYNE
Owner State:  PA
Owner ZIP Code:  19087
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  Yes
Is Ten Percent Owner?  No
Is Other?  No
Officer Title:  INTERIM PRESIDENT AND CEO
Other Text:
Aff 10b5 One:  0
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  4/1/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  9,467
Transaction Price Per Share:
Footnote ID:  F1
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  1,288,912
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Nature of Ownership:
Value:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  4/1/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  F
Equity Swap Involved?  No
Footnote ID:  F2
Transaction Amounts:
Transaction Shares:
Value:  3,224
Transaction Price Per Share:
Value:  1.26
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  1,285,688
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Nature of Ownership:
Value:
Derivative Table:
Derivative Transaction:
Security Title:
Value:  Restricted Stock Units
Conversion or Exercise Price:
Footnote ID:  F1
Transaction Date:
Value:  4/1/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  9,467
Transaction Price Per Share:
Value:  0
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F3
Expiration Date:
Footnote ID:  F3
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  9,467
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  123,067
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Nature of Ownership:
Value:
Footnotes:
Footnote - F1:  Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Footnote - F2:  The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
Footnote - F3:  The shares vest in equal monthly installments over 15 months beginning February 1, 2024, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as the Interim CEO to the Company as of each such vesting date, provided that in the event he ceases to be Interim CEO but continues to provide Continuous Service in any capacity, such awards will continue to vest in the event that the Issuer's Board of Directors determines in its sole discretion that he achieved the Performance Goals (as defined in his letter agreement of employment as Interim CEO) prior to the cessation of his employment as Interim CEO.
Owner Signature:
Signature Name:  /s/ Matthew Rothman, Attorney-in-Fact
Signature Date:  4/3/24


↑Top
Filing Submission 0001415889-24-010060   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 4:40:35.2am ET